First Horizon Corporation’s Ligand Pharmaceuticals LGND Stock Holding History

First Horizon Corporation's LGND Position: Q2 2026 in Review

First Horizon Corporation reduced its Ligand Pharmaceuticals (LGND) stake by 47% in Q2 2026, selling an estimated $62.4K and leaving 297 shares worth $93.9K. The position accounts for ﹤0.01% of the portfolio, ranked #547.

First Horizon Corporation first reported a position in LGND in Q3 2020 and has held it in 5 quarters since. The position peaked at $112K in Q1 2026. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

• First Horizon Corporation held 297 shares of Ligand Pharmaceuticals worth $93.9K as of Q2 2026.
• First Horizon Corporation sold 265 Ligand Pharmaceuticals shares in Q2 2026, an estimated $62.4K.
• Ligand Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #547 holding.
• First Horizon Corporation first reported a position in Ligand Pharmaceuticals in Q3 2020 and has held it in 5 quarters since.
• First Horizon Corporation's Ligand Pharmaceuticals position peaked at $112K in Q1 2026.
• 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.